Device / Technology News

RSS

Economic, clinical benefits of HyperQ stress test presented at International Congress on Electrocardiology

BSP Biological Signal Processing Ltd., develops and markets innovative systems for non-invasive diagnosis and monitoring of Ischemic Heart Disease based on its proprietary HyperQ technology. BSP recently presented the results of a study on the economic and clinical benefits of the HyperQ stress test in the diagnosis and management of coronary heart disease at the International Congress on Electrocardiology on June 4th, 2010.

7 Jun 2010

Tranzyme Pharma receives BioQuébec's 2010 Genesis Award for "Innovation"

Tranzyme Pharma, a clinical-stage biopharmaceutical company, announced today that the Company has been awarded BioQuébec's 2010 Genesis Award for "Innovation", having demonstrated strong and proven innovation in the field of life sciences.

7 Jun 2010

Misys, SmartStream Technologies partner to improve trade lifecycle management

Misys plc, the global application software and services company, today announces that it has partnered with SmartStream Technologies to deliver improved risk control and greater efficiency across the entire trade transaction lifecycle.

7 Jun 2010

Telemedicine holds key to rehabilitation of people with stroke: Researcher

Telemedicine holds the key to the rehabilitation of people with stroke living in northern, rural, remote Canadian communities, rehabilitation researcher Esmé French told the Canadian Stroke Congress today.

7 Jun 2010

Raydiance, Rofin partner to offer femtosecond laser technology for manufacture of medical devices

Raydiance, Inc., the innovation leader in ultrafast laser technology, announced today that it is teaming up with Rofin, world-leading manufacturer of laser sources and laser-based solutions for industrial materials processing, to introduce femtosecond laser technology to industrial production.

7 Jun 2010

GE Healthcare highlights molecular imaging technologies to help clinicians improve patient experiences

Focusing on helping clinicians improve experiences for their patients, GE Healthcare is highlighting an innovative portfolio of molecular imaging technologies and agents at the 57th annual meeting of the Society of Nuclear Medicine, June 5-9, in Salt Lake City.

7 Jun 2010

bioTheranostics presents positive outcomes from CancerTYPE ID, Breast Cancer Index clinical studies

bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago.

7 Jun 2010

USA Health System to implement MEDSEEK's eHealth ecoSystem

MEDSEEK, the industry's only provider of the eHealth ecoSystemTM, today announced its engagement to develop and deploy the University of South Alabama Health System's new consumer website in a first step toward implementing the eHealth ecoSystem.

7 Jun 2010

Positive phase III clinical trial data of NovoCure's NovoTTF device for recurrent GBM presented at ASCO

Data from the first phase III clinical trial of NovoCure's NovoTTF device for treatment of patients with recurrent glioblastoma (GBM) were presented today as a late breaking abstract during the Neuro-Oncology session at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Study results show that NovoTTF, a novel, non-invasive, portable medical device, may be as or more effective than the best available chemotherapies for GBM, but without the toxicity usually associated with cytotoxic or targeted treatments.

7 Jun 2010

Multiple study data on Agendia's MammaPrint, BluePrint, and ColoPrint assays to be presented at 2010 ASCO

Agendia, a world leader in molecular cancer diagnostics, today announced that researchers from Agendia and leading academic centers in the U.S. and Europe will present data from multiple studies concerning Agendia's assays MammaPrint(R), BluePrint(TM), and ColoPrint(TM) at the American Society of Clinical Oncology Annual Meeting, June 4 - 8, 2010, at McCormick Place in Chicago. MammaPrint, the company's lead product, is the only FDA-cleared breast cancer recurrence test.

5 Jun 2010

KCI to submit labeling for its products cleared by FDA for home use

Kinetic Concepts, Inc. today announced it is the first manufacturer to commit to submitting labeling for its products used in the home to the Food and Drug Administration as part of the agency's medical device Home Use Initiative. KCI will voluntarily submit labeling for its products cleared by FDA for home use for inclusion in the home use device labeling repository on the FDA's website.

5 Jun 2010

Eye test to detect cattle infected with Mad Cow Disease

The eyes may or may not be windows to the soul, as the old adage goes, but scientists are reporting evidence that a peek into the eyes of cattle may become the basis for a long-sought test to detect infection with the agent that causes Mad Cow Disease. That test could help prevent the disease from spreading in the food supply. A study on using the tell-tale glow given off by eyes infected with the Mad Cow agent appears in ACS' semi-monthly journal Analytical Chemistry.

5 Jun 2010

Researchers assess influence of oral dimensions on MAS treatment success in patients with OSA

According to new research that will receive the Graduate Student Research Award on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, the ratio between tongue volume and bony enclosure size in patients with obstructive sleep apnea may help dentists calculate oral appliance treatment success.

5 Jun 2010

$2M federal grant to double computing power at Southwest Foundation For Biomedical Research

The "computer ranch" at the Southwest Foundation for Biomedical Research (SFBR), one of the world's largest clusters of computers for human gene research, will more than double in size this summer, thanks to a $2 million federal grant that will speed the pace of discovery at the Foundation's AT&T Genomics Computing Center.

5 Jun 2010

Nasendoscopies help predict response to OAT in sleep apnea patients

According to new research that will be presented on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, nasendoscopy may help dentists predict oral appliance therapy success in sleep apnea patients. Nasendoscopy involves a flexible endoscope being inserted through the nasal cavity. The tip of the scope is placed at the level of the velopharynx and oro-/hypopharynx.

5 Jun 2010

Prismatic eyeglass lenses reduce symptoms associated with TBI, vertical heterophoria: Study

A recent retrospective study by four Michigan physicians shows strong evidence that symptoms of headache, dizziness and anxiety in some patients with traumatic brain injury potentially could be alleviated or even eliminated with specialized eyeglass lenses containing prisms.

5 Jun 2010

Siemens Healthcare donates MAGNETOM ESSENZA MRI system to Phoebe Sumter Medical Center

After three long years of hardship to rebuild a cornerstone of the community, the staff of Phoebe Sumter Medical Center welcomed the arrival of a new MAGNETOM® ESSENZA magnetic resonance imaging (MRI) system, compliments of Siemens Healthcare. The new MRI scanner premiered today at the official ribbon-cutting ceremony to mark Siemens' donation after a tornado destroyed the hospital in 2007. State and local political dignitaries and community leaders were on hand for the event.

5 Jun 2010

St. Jude Medical to pay $3.7M to resolve allegations of illegal kickbacks

Working with an internal whistleblower, Attorney Warner Mendenhall, the Law firm of McLaughlin and McCaffrey, LLP, and Assistant United States Attorneys Alex Rokakis and Michelle Heyer have worked for four years to expose False Claims by St. Jude Medical, Inc. a cardiac device manufacturer.

5 Jun 2010

John Theurer Cancer Center to showcase treatment advancements for cancer at ASCO 2010

The John Theurer Cancer Center at Hackensack University Medical Center announced today important research findings that will be presented at the American Society of Clinical Oncology annual meeting taking place June 4 - 8, 2010 in Chicago. Research highlights include a comparison of first-line treatments for an aggressive form of lymphoma, the efficacy and safety of a new genetically engineered cancer therapy, and the value of a commonly used tool for staging lymphoma.

5 Jun 2010

Encore Path signs license agreement for UMB technology that helps stroke patients redevelop natural gait

The University of Maryland, Baltimore's Office of Research and Development announced that Encore Path, Inc. of Baltimore signed an exclusive worldwide license agreement for a device technology invented jointly by researchers at the University of Maryland, Baltimore and the University of Maryland Baltimore County that helps stroke patients retrain their bodies to walk.

5 Jun 2010

Device / Technology News

Economic, clinical benefits of HyperQ stress test presented at International Congress on Electrocardiology

Tranzyme Pharma receives BioQuébec's 2010 Genesis Award for "Innovation"

Misys, SmartStream Technologies partner to improve trade lifecycle management

Telemedicine holds key to rehabilitation of people with stroke: Researcher

Raydiance, Rofin partner to offer femtosecond laser technology for manufacture of medical devices

GE Healthcare highlights molecular imaging technologies to help clinicians improve patient experiences

bioTheranostics presents positive outcomes from CancerTYPE ID, Breast Cancer Index clinical studies

USA Health System to implement MEDSEEK's eHealth ecoSystem

Positive phase III clinical trial data of NovoCure's NovoTTF device for recurrent GBM presented at ASCO

Multiple study data on Agendia's MammaPrint, BluePrint, and ColoPrint assays to be presented at 2010 ASCO

KCI to submit labeling for its products cleared by FDA for home use

Eye test to detect cattle infected with Mad Cow Disease

Researchers assess influence of oral dimensions on MAS treatment success in patients with OSA

$2M federal grant to double computing power at Southwest Foundation For Biomedical Research

Nasendoscopies help predict response to OAT in sleep apnea patients

Prismatic eyeglass lenses reduce symptoms associated with TBI, vertical heterophoria: Study

Siemens Healthcare donates MAGNETOM ESSENZA MRI system to Phoebe Sumter Medical Center

St. Jude Medical to pay $3.7M to resolve allegations of illegal kickbacks

John Theurer Cancer Center to showcase treatment advancements for cancer at ASCO 2010

Encore Path signs license agreement for UMB technology that helps stroke patients redevelop natural gait

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News